Semaglutide peptide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. The drug has gained popularity among medical professionals due to its efficiency in improving glycemic control, reducing cardiovascular risk, and aiding weight loss. Semaglutide works by binding to the GLP-1 receptor, activating it, and stimulating insulin secretion, suppressing glucagon...